Related to this topic: Leaflets | Support | Patient+ | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Heerfordt's Syndrome

Synonyms: Heerfordt syndrome (USA form), Heerfordt's disease, Heerfordt-Mylius syndrome, Heerfordt-Waldenstrom syndrome, Waldenstrom's uveoparotitis, uveoparotid fever, febris uveoparotidae, neuro-uveoparotitis syndrome, uveoparotitic paralysis, uveomeningitic syndrome

See also: Sarcoidosis.
An acute syndromal presentation of sarcoidosis. Several physicians were involved in its discovery and characterisation,1 hence its plethora of eponymous names. It forms a small proportion (<5%) of sarcoidosis cases, with variation in its likelihood between ethnic groups. Its classical combination of features is virtually pathognomonic of sarcoidosis.

Definition of the syndrome

Sarcoidosis presenting with the following features:

  • Fever
  • Uveitis
  • Swelling of parotid ± other salivary/lacrimal glands
  • Facial nerve palsy may be a feature but is not thought necessary to confirm the syndrome by all authors.

Involvement of the eyes, nervous system and salivary glands in isolation occurs frequently in sarcoidosis. To strictly fit the criteria of this syndrome they must all present in combination, along with episodes of fever.

Other features of sarcoidosis may co-exist with the syndrome, such as skin lesions and evidence of thoracic involvement. It represents a form of neurosarcoidosis, so there may be other neurological involvement such as meningism, or other cranial nerve lesions leading to ophthalmoplegia, pupillary reflex dysfunction or other abnormalities.2

Epidemiology

The overall US prevalence of sarcoidosis is estimated at 10–40 cases per 100,000 population but its prevalence in Irish- Scandinavian- and Caribbean-origin populations appears to be highest in the US. The lifetime prevalence of sarcoidosis for North Americans is 2.4% in the black population, and 0.85% in whites.

Heerfordt's syndrome is relatively rare and accounts for <5% of presentations of the parent disease. Parotid gland involvement in UK sarcoidosis sufferers had a prevalence of 6% in one series, but not all of these cases could be classified as Heerfordt's syndrome.3 In a series of 147 patients with ocular sarcoidosis, facial palsy occurred in 12% and parotid gland enlargement in 10%.4

Risk factors

It appears to be a more common presentation in white patients, particularly those of Scandinavian origin. There is an appreciable low-level incidence in the Japanese population.5

Presentation

Presents most commonly in young adults, usually aged 20–40 years.3 Other features of sarcoidosis may appear alongside the syndrome. For full details of sarcoidosis presentations see the separate article on sarcoidosis.

Symptoms

  • Fever and constitutional upset:
    • The patient may have experienced episodes of fever or night sweats.
    • Other symptoms such as headache and weight loss may occur.6
  • Ocular symptoms:
    • Acute uveitis presents with ocular discomfort, photophobia, blurred vision, seeing floaters and a red eye.
    • The lacrimal glands may be involved, causing puffy eyelids.6
  • Parotid swelling:
    • Unilateral or bilateral (affects both sides in 73% of cases of parotid sarcoidosis).3
    • Diffuse, painless swelling of the parotid ± other salivary glands/lacrimal glands.
    • May cause a dry mouth.
  • Cranial Nerve Palsy:
    • Strictly speaking must affect Facial Nerve (CN VII).
    • Abrupt onset within short period of parotid swelling.
    • Nerve thought to be entrapped/infiltrated by granulomatous inflammation in parotid gland or facial canal, but site still uncertain.
    • May be accompanying disturbance of taste (chorda tympani dysfunction – supporting presumed site of lesion).
    • Other cranial nerves can be involved.
    • Symptoms of other cranial neuropathies commonly involved in neurosarcoidosis include disturbance of smell, blurred vision/diplopia/blindness, speech or swallowing difficulty, vertigo/deafness/tinnitus, weakness of trapezius/neck muscles and tongue deviation or atrophy.7

Signs

  • General/observation:
    • Pyrexia, possibly evidence of weight loss, facial swelling around the cheeks, maybe swollen eyes.
    • Patient has inflamed eyes and may squint in light.
    • May be visible facial nerve palsy with drooping of features on one side (can be bilateral when facial symmetry may be preserved).
  • Cranial nerve palsy:
    • Lower-motor-neurone VIIth CN lesion, affecting the whole face including forehead and eyelids.
    • Bell's phenomenon may be seen – upward, outward turning of the eyeball as the patient attempts to close the eyelids.
    • Examine other cranial nerves as other palsies may be found.
    • If alternative cranial nerve palsy found in place of Facial Nerve paralysis, most would still define the syndrome as Heerfordt's, where all other classical features of the syndrome are present.
    • Bilateral lower-motor-neurone facial nerve palsy of abrupt onset in young adults is virtually always due to sarcoidosis.
    • There may be accompanying signs of meningism.
  • Eyes:
    • Anterior uveitis is painful and presents with miosis, pupillary irregularity and injected conjunctivae next to the cornea (so-called perilimbal flush).
    • Fundoscopy may show retinal detachment or vasculitis and papilloedema if there is posterior uveitis.
    • Severe cases may show hypopyon – a collection of yellowish inflammatory exudate and cells at the bottom of the anterior chamber.
    • Slit lamp examination may reveal cells, flare and precipitates in the anterior chamber/vitreous humour.
    • See internet section below for link to image of uveitic eye.
  • Salivary/lacrimal glands:
    • Diffuse, firm swelling which is not tender to palpation.

It is important to conduct a thorough examination of the heart, chest, skin, eyes, joints, abdomen, lymph fields, nervous system, salivary glands and upper respiratory tract in all patients presenting with suspected sarcoidosis to detect the full extent of the disease.

Differential Diagnosis

The syndrome is a fairly distinct clinical entity and once recognised is not likely to be confused with illnesses other than sarcoidosis, being virtually pathognomonic for the disease. Sarcoidosis has a vast differential diagnosis, depending on its mode of presentation. See separate article. The differential diagnoses of uveitis and facial nerve palsy are discussed in separate articles.

Parotid enlargement may be caused by:

Investigations

The two most useful specific tests for this presentation of sarcoidosis are:

  • Serum Angiotensin Converting Enzyme (ACE) which is usually elevated.
  • Scintigraphy using Gallium 67 which shows increased uptake in the parotid gland, signifying active sarcoidosis.
  • Scintigraphy may reveal other sites of active sarcoidosis.
  • These 2 tests combined have a specificity of 99%.8
  • Biopsy of the parotid gland or other sites of disease may be required in some cases (shows characteristic non-caseating epithelioid granulomata).

CXR should be carried out to look for evidence of hilar adenopathy or pulmonary involvement. Basic screening bloods such as ESR, FBC, U&E/LFTs are usually performed as baseline investigations but are fairly non-specific. If there is any suspicion of a connective tissue disease then autoantibody determination may be useful. Lumbar puncture may be needed where there is suspicion of meningitis. It shows a sterile pleomorphic inflammatory picture.

Management

Sarcoidosis tends to undergo spontaneous remission in 50–60% of cases and does not always require active management. The disease course is very variable and difficult to predict. See separate article for full details.

Medical

The most troublesome aspect of the syndrome to manage is uveitis which may be sight-threatening and requires expert ophthalmological assessment and monitoring. Topical or systemic corticosteroids are the mainstays of management of ocular sarcoidosis. Other immunomodulatory drugs may be used as steroid-sparing or disease-modifying agents.9 Systemic steroids are used to treat the facial nerve palsy if it is troublesome enough and does not resolve, usually successfully.

Surgical

Surgical intervention may be used to treat the complications of cataracts or vitreous opacification, once active disease has been controlled. Uveitis increases the risk of glaucoma, so a significant proportion of patients may require trabeculectomy or other glaucoma-drainage devices.9

Complications

See separate article on sarcoidosis for details of its protean manifestations and complications, that may affect nearly all the tissues of the body

Prognosis

Very variable. Facial paralysis tend to recover or respond to steroids. Of the acute presentations of sarcoidosis, it carries a relatively poorer outlook in terms of severity of disease, but permanent complications can be avoided or ameliorated by adequate management in many cases. Heerfordt's syndrome is not thought to relapse once it has remitted or responded to therapy, but other patterns of sarcoidosis may follow it. The degree of involvement of sarcoidosis at other sites will influence the overall prognosis. Overall long-term mortality in sarcoidosis is about 5-8%.10

Prevention

The cause of sarcoidosis is not really understood so primary preventive strategies do not exist. Patients with sarcoidosis are prone to relapse and may benefit from long-term specialist follow up. Patients should be advised to seek early help if they experience symptoms potentially attributable to sarcoidosis.


Document References
  1. Whonamedit.com; Historical detail behind the syndrome and those associated with it
  2. Blair MP, Rizen M; Heerfordt syndrome with internal ophthalmoplegia.; Arch Ophthalmol. 2005 Jul;123(7):1017.
  3. James DG, Sharma OP; Parotid gland sarcoidosis.; Sarcoidosis Vasc Diffuse Lung Dis. 2000 Mar;17(1):27-32. [abstract]
  4. James DG; Differential diagnosis of facial nerve palsy.; Sarcoidosis Vasc Diffuse Lung Dis. 1997 Sep;14(2):115-20. [abstract]
  5. Takahashi N, Horie T; [Heerfordt syndrome]; Nippon Rinsho. 2002 Sep;60(9):1822-6. [abstract]
  6. Herrmann G; [Parotid swelling with night sweat, fever and weight loss symptoms. A rare differential diagnosis]; Dtsch Med Wochenschr. 1999 Feb 26;124(8):209-12. [abstract]
  7. Bucurescu G and Suleman A; eMedicine, Neurosarcoidosis, 2005.; Good overview of neurological presentations of sarcoidosis.
  8. Sagowski C, Ussmuller J; [Clinical diagnosis of salivary gland sarcoidosis (Heerfordt syndrome)]; HNO. 2000 Aug;48(8):613-5. [abstract]
  9. De Barge L; Sarcoidosis, eMedicine, 2005; Good review of ocular aspects of sarcoidosis
  10. Belfer M and Wayne Stevens R; Sarcoidosis: A Primary Care Review.; Am Fam Phys 1998 Dec;58(9):2041-2054 [Full Text]

Internet and Further Reading Acknowledgements EMIS is grateful to Dr Sean Kavanagh for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 951
Document Version: 20
DocRef: bgp1892
Last Updated: 18 Aug 2006
Review Date: 17 Aug 2008






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page